4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000010
Chief Commercial Officer gave up 590 shares (to pay taxes)
- Chief Commercial Officer acquired 1,738 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Poddar Richa · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-14 | Exercise or conversion : show line 1 in the form | +1,738 | 3,231 | D | ||
| 2022-02-14 | Shares withheld for taxes : show line 2 in the form | −590 | $30.50 | $17,995 | 2,641 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-14 | Exercise or conversion : show line 3 in the form Restricted stock units | −1,738 | 1,738 | D |
Loading xslF345X03/wf-form4_164504883633702.xml…